A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy
- PMID: 3109916
- DOI: 10.1007/BF00252644
A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy
Abstract
Four color processed whole body bone scintigraphy with 99mTc-methylene diphosphonate was performed in six patients on maintenance hemodialysis, and the results of semiquantitative colorimetric analysis were compared with those of a normal group. The difference between the two (control and patient group) was statistically significant (P less than 0.01). Furthermore, the effect of 1 alpha-hydroxyvitamin D3 treatment on renal osteodystrophy was evaluated by this method. The results indicated that this method provides a useful method for assessing the response of renal osteodystrophy to treatment. Two representative cases of renal osteodystrophy are presented to illustrate the usefulness of this approach to semiquantitative whole body bone scanning.
Similar articles
-
Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.J Nucl Med. 1998 Mar;39(3):541-3. J Nucl Med. 1998. PMID: 9529307
-
A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.Ann Nucl Med. 2004 Sep;18(6):513-8. doi: 10.1007/BF02984569. Ann Nucl Med. 2004. PMID: 15515752 Clinical Trial.
-
[Bone scintigraphy in evaluation of the effect of renal transplantation in patients with renal osteodystrophy].Rinsho Hoshasen. 1989 Nov;34(12):1433-6. Rinsho Hoshasen. 1989. PMID: 2593286 Japanese.
-
[Radioisotope studies of the bones in renal osteodystrophy].Pol Tyg Lek. 1987 May 4;42(18):562-4. Pol Tyg Lek. 1987. PMID: 3306627 Review. Polish. No abstract available.
-
Radiophosphate imaging and bone densitometry in renal osteodystrophy.Curr Opin Nephrol Hypertens. 1993 Nov;2(6):956-61. doi: 10.1097/00041552-199311000-00016. Curr Opin Nephrol Hypertens. 1993. PMID: 7922239 Review.